This review outlines the historical development and current evidence supporting the efficacy of novel renin inhibitors for hypertension management.
Answers are grounded in this paper and cite their sources.
Novel renin inhibitors should not yet change hypertension practice; this review extends prior summaries but leaves key questions open.
The idea of renin inhibition is not new, and evidence of attempts to block its activity can be found in the literature as early as the 1950s. Throughout the latter half of the 20th century, development of renin inhibitors encountered many problems. Only recently, after the x-ray crystallography of its active site, new and effective renin inhibitors have been developed. The purpose of this review is to describe the basic evidence to support the efficacy of these agents and to elaborate on new possibilities of their use and combination with other antihypertensive drugs.
No takes yet. Share an insight, caveat, or question.
Leibovitz et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: